AYTU BIOPHARMA, INC Proceeds from Issuance of Warrants
AYTU BIOPHARMA, INC (AYTU) reported Proceeds from Issuance of Warrants of $2.85 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2017-08-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2018-02-08
- AYTU BIOPHARMA, INC proceeds from issuance of warrants for the quarter ending 2017-06-30 was $0.00.
- AYTU BIOPHARMA, INC proceeds from issuance of warrants for the quarter ending 2017-03-31 was $0.00.
- AYTU BIOPHARMA, INC proceeds from issuance of warrants for the quarter ending 2016-06-30 was $0.00.
- AYTU BIOPHARMA, INC proceeds from issuance of warrants for fiscal 2017 was $2.85K.
- AYTU BIOPHARMA, INC proceeds from issuance of warrants for fiscal 2016 was $0.00.
| Period end | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $0.00 derived: sum of 2 quarters · filed 2017-08-31 | $2.85K 10-K · filed 2017-08-31 | ||
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $2.85K 10-Q · filed 2017-05-11 | |||
| 2017-02-28 | $2.20M 10-K · filed 2017-08-31 | ||||
| 2016-12-31 | $2.85K 10-Q · filed 2018-02-08 | ||||
| 2016-11-30 | $3.00K 10-K · filed 2017-08-31 | ||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $0.00 10-K · filed 2017-08-31 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |